SEC INSIDER TRANSACTIONS

Moderna, Inc. (MRNA) Insider Transactions

Explore official ownership filings, with every record linked to its source.

Reported data · not live

MRNA · Moderna, Inc.

Filing window SEC codes (comma separated) Security type Order

More transaction filters

Roles: director,officer,ten_percent_owner,otherOwner nameOfficer titleOwnership: D, I, unknownoriginal or amendedTransaction fromTransaction throughFiled fromFiled throughMinimum quantityMaximum quantityMinimum priceMaximum priceMinimum calculated valueMaximum calculated valueResults per page (1–100)

OR within codes/roles; AND between categories. Roles apply to buyers and sellers. Owner predicates match the same owner. Missing values fail numeric/date filters. Value is quantity × reported price for non-derivative rows only; derivative values are unknown. Amendments stay separate; joint owners do not duplicate rows.

Reset filters

Active filters: days=6m

Stale snapshot · Covered: filings 2026-05-14 to 2026-11-13 · 32 filings · fetched 2026-11-13T18:57:57Z

Recent reported activity

0purchase rows on this page

1sale rows on this page

130matching filing rows

Purchases and sales count original non-derivative P and S rows. Awards, gifts, exercises, derivatives and amendments are shown separately and are not described as market purchases.

Transaction / filed	Reporting owner(s)	Code / security	Quantity	Price as filed	Ownership	Source
2026-06-01Filed 2026-06-03	Klinger Shannon ThymeOfficer · Chief Legal Officer Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Restricted stock units convert into common stock on a one-for-one basis. F2 Represents shares withheld at the election of the Reporting Person to satisfy tax withholding obligations in connection with the vest of restricted stock units. F3 25% of the shares subject to this restricted stock unit award vested on March 1, 2026 with the remainder vesting in twelve (12) equal quarterly installments thereafter. References: F1	M Exercise / conversionCommon Stock · Non-derivative	2,165A	—	Direct	Form 4 ↗0001682852-26-000113
2026-06-01Filed 2026-06-03	Hoge StephenOfficer · President Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Restricted stock units convert into common stock on a one-for-one basis. F2 Represents shares withheld at the election of the Reporting Person to satisfy tax withholding obligations in connection with the vest of restricted stock units. F3 These shares are owned directly by a trust for the benefit of Dr. Hoge's spouse and children, of which his spouse is a trustee. The reporting person disclaims Section 16 beneficial ownership of these securities, except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for Section 16 or any other purpose. F4 25% of the shares subject to this restricted stock unit award vested on March 1, 2026 with the remainder vesting in twelve (12) equal quarterly installments thereafter. References: F1, F4	M Exercise / conversionRestricted Stock Units · Derivative	9,282D	0	Direct	Form 4 ↗0001682852-26-000111
2026-06-01Filed 2026-06-03	Hoge StephenOfficer · President Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Restricted stock units convert into common stock on a one-for-one basis. F2 Represents shares withheld at the election of the Reporting Person to satisfy tax withholding obligations in connection with the vest of restricted stock units. F3 These shares are owned directly by a trust for the benefit of Dr. Hoge's spouse and children, of which his spouse is a trustee. The reporting person disclaims Section 16 beneficial ownership of these securities, except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for Section 16 or any other purpose. F4 25% of the shares subject to this restricted stock unit award vested on March 1, 2026 with the remainder vesting in twelve (12) equal quarterly installments thereafter. References: F2	F WithholdingCommon Stock · Non-derivative	4,488D	47.19	Direct	Form 4 ↗0001682852-26-000111
2026-06-01Filed 2026-06-03	Hoge StephenOfficer · President Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Restricted stock units convert into common stock on a one-for-one basis. F2 Represents shares withheld at the election of the Reporting Person to satisfy tax withholding obligations in connection with the vest of restricted stock units. F3 These shares are owned directly by a trust for the benefit of Dr. Hoge's spouse and children, of which his spouse is a trustee. The reporting person disclaims Section 16 beneficial ownership of these securities, except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for Section 16 or any other purpose. F4 25% of the shares subject to this restricted stock unit award vested on March 1, 2026 with the remainder vesting in twelve (12) equal quarterly installments thereafter. References: F1	M Exercise / conversionCommon Stock · Non-derivative	9,282A	—	Direct	Form 4 ↗0001682852-26-000111
2026-05-28Filed 2026-05-29	Mock James MOfficer · Chief Financial Officer Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Restricted stock units convert into common stock on a one-for-one basis. F2 Represents shares withheld at the election of the Reporting Person to satisfy tax withholding obligations in connection with the vest of restricted stock units. F3 25% of the shares subject to this restricted stock unit award vested on February 27, 2025 with the remainder vesting in twelve (12) equal quarterly installments thereafter. F4 25% of the shares subject to this restricted stock unit award vested on February 28, 2024 with the remainder vesting in twelve (12) equal quarterly installments thereafter. References: F1, F4	M Exercise / conversionRestricted Stock Units · Derivative	328D	0	Direct	Form 4 ↗0001682852-26-000109
2026-05-28Filed 2026-05-29	Mock James MOfficer · Chief Financial Officer Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Restricted stock units convert into common stock on a one-for-one basis. F2 Represents shares withheld at the election of the Reporting Person to satisfy tax withholding obligations in connection with the vest of restricted stock units. F3 25% of the shares subject to this restricted stock unit award vested on February 27, 2025 with the remainder vesting in twelve (12) equal quarterly installments thereafter. F4 25% of the shares subject to this restricted stock unit award vested on February 28, 2024 with the remainder vesting in twelve (12) equal quarterly installments thereafter. References: F2	F WithholdingCommon Stock · Non-derivative	159D	47.61	Direct	Form 4 ↗0001682852-26-000109
2026-05-28Filed 2026-05-29	Mock James MOfficer · Chief Financial Officer Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Restricted stock units convert into common stock on a one-for-one basis. F2 Represents shares withheld at the election of the Reporting Person to satisfy tax withholding obligations in connection with the vest of restricted stock units. F3 25% of the shares subject to this restricted stock unit award vested on February 27, 2025 with the remainder vesting in twelve (12) equal quarterly installments thereafter. F4 25% of the shares subject to this restricted stock unit award vested on February 28, 2024 with the remainder vesting in twelve (12) equal quarterly installments thereafter. References: F1	M Exercise / conversionCommon Stock · Non-derivative	328A	—	Direct	Form 4 ↗0001682852-26-000109
2026-05-28Filed 2026-05-29	Klinger Shannon ThymeOfficer · Chief Legal Officer Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Restricted stock units convert into common stock on a one-for-one basis. F2 Represents shares withheld at the election of the Reporting Person to satisfy tax withholding obligations in connection with the vest of restricted stock units. F3 25% of the shares subject to this restricted stock unit award vested on February 27, 2025 with the remainder vesting in twelve (12) equal quarterly installments thereafter. F4 25% of the shares subject to this restricted stock unit award vested on February 28, 2024 with the remainder vesting in twelve (12) equal quarterly installments thereafter. References: F1, F4	M Exercise / conversionRestricted Stock Units · Derivative	328D	0	Direct	Form 4 ↗0001682852-26-000107
2026-05-28Filed 2026-05-29	Klinger Shannon ThymeOfficer · Chief Legal Officer Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Restricted stock units convert into common stock on a one-for-one basis. F2 Represents shares withheld at the election of the Reporting Person to satisfy tax withholding obligations in connection with the vest of restricted stock units. F3 25% of the shares subject to this restricted stock unit award vested on February 27, 2025 with the remainder vesting in twelve (12) equal quarterly installments thereafter. F4 25% of the shares subject to this restricted stock unit award vested on February 28, 2024 with the remainder vesting in twelve (12) equal quarterly installments thereafter. References: F2	F WithholdingCommon Stock · Non-derivative	159D	47.61	Direct	Form 4 ↗0001682852-26-000107
2026-05-28Filed 2026-05-29	Klinger Shannon ThymeOfficer · Chief Legal Officer Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Restricted stock units convert into common stock on a one-for-one basis. F2 Represents shares withheld at the election of the Reporting Person to satisfy tax withholding obligations in connection with the vest of restricted stock units. F3 25% of the shares subject to this restricted stock unit award vested on February 27, 2025 with the remainder vesting in twelve (12) equal quarterly installments thereafter. F4 25% of the shares subject to this restricted stock unit award vested on February 28, 2024 with the remainder vesting in twelve (12) equal quarterly installments thereafter. References: F1	M Exercise / conversionCommon Stock · Non-derivative	328A	—	Direct	Form 4 ↗0001682852-26-000107
2026-05-28Filed 2026-05-29	Hoge StephenOfficer · President Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Restricted stock units convert into common stock on a one-for-one basis. F2 Represents shares withheld at the election of the Reporting Person to satisfy tax withholding obligations in connection with the vest of restricted stock units. F3 These shares are owned directly by a trust for the benefit of Dr. Hoge's spouse and children, of which his spouse is a trustee. The reporting person disclaims Section 16 beneficial ownership of these securities, except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for Section 16 or any other purpose. F4 25% of the shares subject to this restricted stock unit award vested on February 27, 2025 with the remainder vesting in twelve (12) equal quarterly installments thereafter. F5 25% of the shares subject to this restricted stock unit award vested on February 28, 2024 with the remainder vesting in twelve (12) equal quarterly installments thereafter. References: F1, F5	M Exercise / conversionRestricted Stock Units · Derivative	610D	0	Direct	Form 4 ↗0001682852-26-000105
2026-05-28Filed 2026-05-29	Hoge StephenOfficer · President Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Restricted stock units convert into common stock on a one-for-one basis. F2 Represents shares withheld at the election of the Reporting Person to satisfy tax withholding obligations in connection with the vest of restricted stock units. F3 These shares are owned directly by a trust for the benefit of Dr. Hoge's spouse and children, of which his spouse is a trustee. The reporting person disclaims Section 16 beneficial ownership of these securities, except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for Section 16 or any other purpose. F4 25% of the shares subject to this restricted stock unit award vested on February 27, 2025 with the remainder vesting in twelve (12) equal quarterly installments thereafter. F5 25% of the shares subject to this restricted stock unit award vested on February 28, 2024 with the remainder vesting in twelve (12) equal quarterly installments thereafter. References: F2	F WithholdingCommon Stock · Non-derivative	295D	47.61	Direct	Form 4 ↗0001682852-26-000105
2026-05-28Filed 2026-05-29	Hoge StephenOfficer · President Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Restricted stock units convert into common stock on a one-for-one basis. F2 Represents shares withheld at the election of the Reporting Person to satisfy tax withholding obligations in connection with the vest of restricted stock units. F3 These shares are owned directly by a trust for the benefit of Dr. Hoge's spouse and children, of which his spouse is a trustee. The reporting person disclaims Section 16 beneficial ownership of these securities, except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for Section 16 or any other purpose. F4 25% of the shares subject to this restricted stock unit award vested on February 27, 2025 with the remainder vesting in twelve (12) equal quarterly installments thereafter. F5 25% of the shares subject to this restricted stock unit award vested on February 28, 2024 with the remainder vesting in twelve (12) equal quarterly installments thereafter. References: F1	M Exercise / conversionCommon Stock · Non-derivative	610A	—	Direct	Form 4 ↗0001682852-26-000105
2026-05-27Filed 2026-05-29	Mock James MOfficer · Chief Financial Officer Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Restricted stock units convert into common stock on a one-for-one basis. F2 Represents shares withheld at the election of the Reporting Person to satisfy tax withholding obligations in connection with the vest of restricted stock units. F3 25% of the shares subject to this restricted stock unit award vested on February 27, 2025 with the remainder vesting in twelve (12) equal quarterly installments thereafter. F4 25% of the shares subject to this restricted stock unit award vested on February 28, 2024 with the remainder vesting in twelve (12) equal quarterly installments thereafter. References: F1, F3	M Exercise / conversionRestricted Stock Units · Derivative	773D	0	Direct	Form 4 ↗0001682852-26-000109
2026-05-27Filed 2026-05-29	Mock James MOfficer · Chief Financial Officer Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Restricted stock units convert into common stock on a one-for-one basis. F2 Represents shares withheld at the election of the Reporting Person to satisfy tax withholding obligations in connection with the vest of restricted stock units. F3 25% of the shares subject to this restricted stock unit award vested on February 27, 2025 with the remainder vesting in twelve (12) equal quarterly installments thereafter. F4 25% of the shares subject to this restricted stock unit award vested on February 28, 2024 with the remainder vesting in twelve (12) equal quarterly installments thereafter. References: F2	F WithholdingCommon Stock · Non-derivative	374D	47.03	Direct	Form 4 ↗0001682852-26-000109
2026-05-27Filed 2026-05-29	Mock James MOfficer · Chief Financial Officer Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Restricted stock units convert into common stock on a one-for-one basis. F2 Represents shares withheld at the election of the Reporting Person to satisfy tax withholding obligations in connection with the vest of restricted stock units. F3 25% of the shares subject to this restricted stock unit award vested on February 27, 2025 with the remainder vesting in twelve (12) equal quarterly installments thereafter. F4 25% of the shares subject to this restricted stock unit award vested on February 28, 2024 with the remainder vesting in twelve (12) equal quarterly installments thereafter. References: F1	M Exercise / conversionCommon Stock · Non-derivative	773A	—	Direct	Form 4 ↗0001682852-26-000109
2026-05-27Filed 2026-05-29	Klinger Shannon ThymeOfficer · Chief Legal Officer Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Restricted stock units convert into common stock on a one-for-one basis. F2 Represents shares withheld at the election of the Reporting Person to satisfy tax withholding obligations in connection with the vest of restricted stock units. F3 25% of the shares subject to this restricted stock unit award vested on February 27, 2025 with the remainder vesting in twelve (12) equal quarterly installments thereafter. F4 25% of the shares subject to this restricted stock unit award vested on February 28, 2024 with the remainder vesting in twelve (12) equal quarterly installments thereafter. References: F1, F3	M Exercise / conversionRestricted Stock Units · Derivative	773D	0	Direct	Form 4 ↗0001682852-26-000107
2026-05-27Filed 2026-05-29	Klinger Shannon ThymeOfficer · Chief Legal Officer Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Restricted stock units convert into common stock on a one-for-one basis. F2 Represents shares withheld at the election of the Reporting Person to satisfy tax withholding obligations in connection with the vest of restricted stock units. F3 25% of the shares subject to this restricted stock unit award vested on February 27, 2025 with the remainder vesting in twelve (12) equal quarterly installments thereafter. F4 25% of the shares subject to this restricted stock unit award vested on February 28, 2024 with the remainder vesting in twelve (12) equal quarterly installments thereafter. References: F2	F WithholdingCommon Stock · Non-derivative	374D	47.03	Direct	Form 4 ↗0001682852-26-000107
2026-05-27Filed 2026-05-29	Klinger Shannon ThymeOfficer · Chief Legal Officer Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Restricted stock units convert into common stock on a one-for-one basis. F2 Represents shares withheld at the election of the Reporting Person to satisfy tax withholding obligations in connection with the vest of restricted stock units. F3 25% of the shares subject to this restricted stock unit award vested on February 27, 2025 with the remainder vesting in twelve (12) equal quarterly installments thereafter. F4 25% of the shares subject to this restricted stock unit award vested on February 28, 2024 with the remainder vesting in twelve (12) equal quarterly installments thereafter. References: F1	M Exercise / conversionCommon Stock · Non-derivative	773A	—	Direct	Form 4 ↗0001682852-26-000107
2026-05-27Filed 2026-05-29	Hoge StephenOfficer · President Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Restricted stock units convert into common stock on a one-for-one basis. F2 Represents shares withheld at the election of the Reporting Person to satisfy tax withholding obligations in connection with the vest of restricted stock units. F3 These shares are owned directly by a trust for the benefit of Dr. Hoge's spouse and children, of which his spouse is a trustee. The reporting person disclaims Section 16 beneficial ownership of these securities, except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for Section 16 or any other purpose. F4 25% of the shares subject to this restricted stock unit award vested on February 27, 2025 with the remainder vesting in twelve (12) equal quarterly installments thereafter. F5 25% of the shares subject to this restricted stock unit award vested on February 28, 2024 with the remainder vesting in twelve (12) equal quarterly installments thereafter. References: F1, F4	M Exercise / conversionRestricted Stock Units · Derivative	1,437D	0	Direct	Form 4 ↗0001682852-26-000105
2026-05-27Filed 2026-05-29	Hoge StephenOfficer · President Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Restricted stock units convert into common stock on a one-for-one basis. F2 Represents shares withheld at the election of the Reporting Person to satisfy tax withholding obligations in connection with the vest of restricted stock units. F3 These shares are owned directly by a trust for the benefit of Dr. Hoge's spouse and children, of which his spouse is a trustee. The reporting person disclaims Section 16 beneficial ownership of these securities, except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for Section 16 or any other purpose. F4 25% of the shares subject to this restricted stock unit award vested on February 27, 2025 with the remainder vesting in twelve (12) equal quarterly installments thereafter. F5 25% of the shares subject to this restricted stock unit award vested on February 28, 2024 with the remainder vesting in twelve (12) equal quarterly installments thereafter. References: F2	F WithholdingCommon Stock · Non-derivative	695D	47.03	Direct	Form 4 ↗0001682852-26-000105
2026-05-27Filed 2026-05-29	Hoge StephenOfficer · President Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Restricted stock units convert into common stock on a one-for-one basis. F2 Represents shares withheld at the election of the Reporting Person to satisfy tax withholding obligations in connection with the vest of restricted stock units. F3 These shares are owned directly by a trust for the benefit of Dr. Hoge's spouse and children, of which his spouse is a trustee. The reporting person disclaims Section 16 beneficial ownership of these securities, except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for Section 16 or any other purpose. F4 25% of the shares subject to this restricted stock unit award vested on February 27, 2025 with the remainder vesting in twelve (12) equal quarterly installments thereafter. F5 25% of the shares subject to this restricted stock unit award vested on February 28, 2024 with the remainder vesting in twelve (12) equal quarterly installments thereafter. References: F1	M Exercise / conversionCommon Stock · Non-derivative	1,437A	—	Direct	Form 4 ↗0001682852-26-000105
2026-05-21Filed 2026-05-22	AFEYAN NOUBARDirector Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 On May 21, 2026, Flagship Pioneering, LLC ("Flagship Pioneering") exercised options to purchase 9,263 shares of the Issuer's Common Stock at $19.15 per share, which options were set to expire on August 10, 2026. F2 The securities are held directly by Flagship Pioneering. Flagship Pioneering is contractually obligated to transfer and/or remit the proceeds of any sale of shares to Flagship Fund IV, L.P. ("Flagship Fund IV"). The reporting person is the ultimate control person of Flagship Pioneering and disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein. F3 The securities are held directly by Flagship Fund IV. Flagship Ventures Fund IV General Partner LLC ("Flagship Fund IV GP") is the general partner of Flagship Fund IV. The reporting person is the sole manager of Flagship Fund IV GP and disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein. F4 The securities are held directly by Flagship Ventures Fund IV-Rx, L.P. ("Flagship Fund IV-Rx"). Flagship Fund IV GP is the general partner of Flagship Fund IV-Rx. The reporting person disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein. F5 The options were fully vested and exercisable. References: F1, F5, F2	M Exercise / conversionStock Option (Right to Buy) · Derivative	9,263D	0	IndirectBy Flagship Pioneering, LLC	Form 4 ↗0001193125-26-237309
2026-05-21Filed 2026-05-22	AFEYAN NOUBARDirector Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 On May 21, 2026, Flagship Pioneering, LLC ("Flagship Pioneering") exercised options to purchase 9,263 shares of the Issuer's Common Stock at $19.15 per share, which options were set to expire on August 10, 2026. F2 The securities are held directly by Flagship Pioneering. Flagship Pioneering is contractually obligated to transfer and/or remit the proceeds of any sale of shares to Flagship Fund IV, L.P. ("Flagship Fund IV"). The reporting person is the ultimate control person of Flagship Pioneering and disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein. F3 The securities are held directly by Flagship Fund IV. Flagship Ventures Fund IV General Partner LLC ("Flagship Fund IV GP") is the general partner of Flagship Fund IV. The reporting person is the sole manager of Flagship Fund IV GP and disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein. F4 The securities are held directly by Flagship Ventures Fund IV-Rx, L.P. ("Flagship Fund IV-Rx"). Flagship Fund IV GP is the general partner of Flagship Fund IV-Rx. The reporting person disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein. F5 The options were fully vested and exercisable. References: F2	S Sale (market/private)Common Stock · Non-derivative	9,263D	46.84	IndirectBy Flagship Pioneering, LLC	Form 4 ↗0001193125-26-237309
2026-05-21Filed 2026-05-22	AFEYAN NOUBARDirector Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 On May 21, 2026, Flagship Pioneering, LLC ("Flagship Pioneering") exercised options to purchase 9,263 shares of the Issuer's Common Stock at $19.15 per share, which options were set to expire on August 10, 2026. F2 The securities are held directly by Flagship Pioneering. Flagship Pioneering is contractually obligated to transfer and/or remit the proceeds of any sale of shares to Flagship Fund IV, L.P. ("Flagship Fund IV"). The reporting person is the ultimate control person of Flagship Pioneering and disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein. F3 The securities are held directly by Flagship Fund IV. Flagship Ventures Fund IV General Partner LLC ("Flagship Fund IV GP") is the general partner of Flagship Fund IV. The reporting person is the sole manager of Flagship Fund IV GP and disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein. F4 The securities are held directly by Flagship Ventures Fund IV-Rx, L.P. ("Flagship Fund IV-Rx"). Flagship Fund IV GP is the general partner of Flagship Fund IV-Rx. The reporting person disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein. F5 The options were fully vested and exercisable. References: F1, F2	M Exercise / conversionCommon Stock · Non-derivative	9,263A	19.15	IndirectBy Flagship Pioneering, LLC	Form 4 ↗0001193125-26-237309

Imported instruments only. Joint owners do not multiply transactions. Amendments are separate filing rows, not additional trades. No aggregate trade totals are implied.